These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 949879)

  • 41. Specific antisera to Clr. Quantitation of Clr in normal and pathological human sera.
    de Bracco MM; Christian CL; Stroud RM
    Clin Exp Immunol; 1974 Mar; 16(3):453-9. PubMed ID: 4219839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative studies of complement and its C3 and C4 component levels in patients with rheumatoid arthritis ans systemic lupus erythematosus].
    Brzezińska B; Bragiel I; Skowrońska H
    Pol Arch Med Wewn; 1976 Oct; 56(3):311-21. PubMed ID: 980923
    [No Abstract]   [Full Text] [Related]  

  • 43. Complement-fixing ability of antinuclear factors. Studies in adult and juvenile rheumatoid arthritis and systemic lupus erythematosus.
    Cossio PM; Arana RM; Morteo OG; Hübscher O; Roux EB
    Ann Rheum Dis; 1971 Nov; 30(6):640-4. PubMed ID: 5316115
    [No Abstract]   [Full Text] [Related]  

  • 44. [Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. I. Variations in the levels of C'1, C'4, C'2 and C'3 and total complement].
    Peltier AP; Vial MC; de Sèze S
    Pathol Biol (Paris); 1970 Nov; 18(21):959-67. PubMed ID: 4921319
    [No Abstract]   [Full Text] [Related]  

  • 45. C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types.
    Agnello V; Koffler D; Eisenberg JW; Winchester RJ; Kundel HG
    J Exp Med; 1971 Sep; 134(3 Pt 2):228s-241s. PubMed ID: 4998931
    [No Abstract]   [Full Text] [Related]  

  • 46. Complement-fixing activity of rheumatoid synovial fluid.
    Townes AS; Marcus RL
    Ann Rheum Dis; 1972 Sep; 31(5):393-401. PubMed ID: 5071634
    [No Abstract]   [Full Text] [Related]  

  • 47. [Immunopathologic reactions in systemic lupus erythematosus and rheumatoid arthritis].
    Tarasenko RV
    Vrach Delo; 1974 Feb; (2):24-7. PubMed ID: 4468615
    [No Abstract]   [Full Text] [Related]  

  • 48. Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes.
    Wallace EM; Perkins SJ; Sim RB; Willis AC; Feighery C; Jackson J
    Mol Med; 1997 Jun; 3(6):385-96. PubMed ID: 9234243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inherited deficiency of the second component of complement. Rheumatic disease associations.
    Glass D; Raum D; Gibson D; Stillman JS; Schur PH
    J Clin Invest; 1976 Oct; 58(4):853-61. PubMed ID: 965492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical significance of complement].
    Wellek B; Opferkuch W
    Dtsch Med Wochenschr; 1973 Dec; 98(49):2356-61. PubMed ID: 4271713
    [No Abstract]   [Full Text] [Related]  

  • 51. Virus antibody levels in rheumatoid arthritis and systemic lupus erythematosus.
    Laitinen O; Vesikari T; Vaheri A
    Acta Med Scand; 1972; 192(1-2):37-40. PubMed ID: 4340721
    [No Abstract]   [Full Text] [Related]  

  • 52. [Complement system in human pathology].
    Tedesco F
    Recenti Prog Med; 1971 Dec; 51(6):501-26. PubMed ID: 5172401
    [No Abstract]   [Full Text] [Related]  

  • 53. Hereditary C2 deficiency in systemic lupus erythematosus and acquired complement abnormalities in an unusual SLE-related syndrome.
    Agnello V; Ruddy S; Winchester RJ; Christian CL; Kunkel HG
    Birth Defects Orig Artic Ser; 1975; 11(1):312-7. PubMed ID: 807273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic lupus erythematosus and complement.
    Schur PH
    Nephrologie; 1988; 9(2):53-60. PubMed ID: 3050577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
    Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
    Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complement deficiency states.
    Agnello V
    Medicine (Baltimore); 1978 Jan; 57(1):1-23. PubMed ID: 337041
    [No Abstract]   [Full Text] [Related]  

  • 57. Familial deficiency of two subunits of the first component of complement. C1r and C1s associated with a lupus erythematosus-like disease.
    Lee SL; Wallace SL; Barone R; Blum L; Chase PH
    Arthritis Rheum; 1978; 21(8):958-67. PubMed ID: 737019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies on synovial fluid in arthritis. I. The total complement activity. II. The occurrence of mononuclear cells with in vitro cytotoxic effect.
    Hedberg H
    Acta Med Scand Suppl; 1967; 479():1-137. PubMed ID: 4172267
    [No Abstract]   [Full Text] [Related]  

  • 59. Venom of the ant Pseudomyrmex sp.: further characterization of two factors that affect human complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1977 Nov; 119(5):1690-9. PubMed ID: 410881
    [No Abstract]   [Full Text] [Related]  

  • 60. Chemical and immunological features of pleural effusions: comparison between rheumatoid arthritis and other diseases.
    Pettersson T; Klockars M; Hellström PE
    Thorax; 1982 May; 37(5):354-61. PubMed ID: 6981226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.